Related Experiment Videos
Piracetam preparations on the Belgian market: a comparative study
J Saevels1, K De Braekeleer, J Corthout
1Service de Contrôle des Médicaments, rue Stévin 137, B-1000 Bruxelles.
Journal De Pharmacie De Belgique
|October 29, 2005
Summary
Piracetam drug products, including capsules, tablets, and granules, were assessed for quality. While most met standards, three formulations failed the United States Pharmacopeia (USP) dissolution criteria.
Area of Science:
- Pharmaceutical Sciences
- Drug Quality Control
Background:
- Piracetam is a widely used nootropic drug.
- Ensuring the quality of pharmaceutical preparations is crucial for patient safety and therapeutic efficacy.
Purpose of the Study:
- To evaluate the quality of various piracetam formulations.
- To assess compliance with European Pharmacopoeia and United States Pharmacopeia (USP) standards.
Main Methods:
- In vitro dissolution testing.
- Assay testing using validated methods.
- Evaluation based on European network of official medicines control laboratories (OMCLs) guidelines.
Main Results:
- All piracetam products met assay requirements.
- Most formulations complied with European Pharmacopoeia standards.
- Three products failed to meet USP dissolution acceptance criteria.
Conclusions:
- While piracetam preparations generally meet quality standards, dissolution profiles require attention.
- Further investigation into the dissolution performance of specific piracetam products is warranted.